These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17554594)

  • 21. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
    Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
    Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
    Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.
    Mueller T; Haltmayer M; Poelz W; Haidinger D
    Vasc Endovascular Surg; 2003; 37(2):117-23. PubMed ID: 12669143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.
    Andersen K; Hurlen M; Arnesen H; Seljeflot I
    Thromb Res; 2002 Oct; 108(1):37-42. PubMed ID: 12586130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Platelets; 2006 Dec; 17(8):586-90. PubMed ID: 17127487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
    Gremmel T; Koppensteiner R; Panzer S
    PLoS One; 2015; 10(6):e0129666. PubMed ID: 26058047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
    Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
    Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
    Pamukcu B; Oflaz H; Oncul A; Umman B; Mercanoglu F; Ozcan M; Meric M; Nisanci Y
    J Thromb Thrombolysis; 2006 Oct; 22(2):103-10. PubMed ID: 17008975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
    Pettersen AA; Seljeflot I; Abdelnoor M; Arnesen H
    Scand Cardiovasc J; 2004 Dec; 38(6):353-6. PubMed ID: 15804802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation.
    Pamukcu B; Oflaz H; Acar RD; Umman S; Koylan N; Umman B; Nisanci Y
    J Thromb Thrombolysis; 2005 Aug; 20(1):17-22. PubMed ID: 16133890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.
    Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R
    Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring aspirin therapy with the Platelet Function Analyzer-100.
    Mortensen J; Poulsen TS; Grove EL; Refsgaard J; Nielsen HL; Pedersen SB; Thygesen SS; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(8):786-92. PubMed ID: 18651324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
    Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
    Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.